wigglethemouse
Senior Member
- Messages
- 776
The 26% improvement on primary outcome was on the 2nd lowest dosing group of 7 patients with a reduction of 26% in symptom scores from 29.2 to 21.7. Here is the data for the primary outcome for all treatment groups fromBut this was not what their data shows as @wigglethemouse showed.
https://clinicaltrials.gov/ct2/show/results/NCT03613129?view=results
Exactly!However, it's still an unblinded trial with subjective measures only, which is unreliable as we have learned from PACE and other BPS model trials. If you repeat the same procedure with placebo pills the expectation is to find a drop in scores there as well so how much significant this really is, I guess we'll find out in a couple of more years.
It sure does.Sounds like a bit of BS.